Comparing the ocular surface effects of topical vancomycin and linezolid for treating bacterial keratitis
CUTANEOUS AND OCULAR TOXICOLOGY, vol.35, no.2, pp.126-130, 2016 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 35 Issue: 2
- Publication Date: 2016
- Doi Number: 10.3109/15569527.2015.1058273
- Journal Name: CUTANEOUS AND OCULAR TOXICOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.126-130
- Bursa Uludag University Affiliated: Yes
Abstract
Background: Vancomycin is the gold standard in combination therapy for severe and resistant gram-positive keratitis and in particular for Methicillin-resistant Staphylococcus aureus (MRSA) infections. The aim of this study was to report the ocular surface toxicity and scoring in patients whose treatment shifted to topical linezolid/ceftazidime from topical vancomycin/ceftazidime due to their vancomycin intolerance.